Plasmon-waveguide resonance spectroscopy applied to three potential drug targets: cyclooxygenase-2, hepatitis C virus RNA polymerase and integrin alpha V beta 3.

Source:http://linkedlifedata.com/resource/pubmed/id/15533662

J Pharm Biomed Anal 2004 Nov 19 36 4 711-9

Download in:

View as

General Info

PMID
15533662